Patients with acute exacerbation of COPD and acute MI who received invasive ventilation with high-concentration oxygen therapy experienced significant improvements in outcomes compared with patients on moderate-concentration oxygen therapy.
Twice-daily ensifentrine was associated with improvements in several symptoms of COPD, including breathlessness, chest symptoms, cough and sputum, and shortness of breath.
A typical usual interstitial pneumonia pattern was the predominant radiologic pattern seen in patients with chronic obstructive pulmonary disease (COPD) and pulmonary hypertension.
Noninvasive ventilation, deep vein puncture/catheterization, bed rest/immobilization, pulmonary heart disease, and type 2 respiratory failure were factors considered to be associated with a higher risk for venous thromboembolism in patients hospitalized with an acute exacerbation of COPD.
Researchers of the study aimed to determine the differences in muscle area and bone density in patients with end-stage lung disease.
Sputum cell count, as measured by a simplified method, was able to differentiate between asthma, COPD, and asthma-COPD overlap.
Influenza vaccination can be modestly effective in reducing laboratory-confirmed influenza-associated hospitalizations in people with chronic obstructive pulmonary disease.
The beneficial effects of tiotropium/olodaterol on resting and operating lung volumes do not translate into enhanced cardiocirculatory responses to exertion in hyperinflated patients with COPD.
The FDA has issued a CRL to AstraZaeneca regarding their NDA for PT010, an investigational triple combination therapy for COPD.
A risk-prediction tool for chronic obstructive pulmonary disease (COPD) has been developed and validated for use in the general population, according to study results published in CHEST. Using the Transparent Reporting of a multivariate prediction model for Individual Prognosis or Diagnosis (or, TRIPOD), researchers sought to develop and validate a personalized tool for predicting changes…
